New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Valley fever cases are up almost 50% in Arizona in 2024. It's not contagious as a person has to be exposed to fungal spores to contract the infection.

November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...

The partnership will focus on supporting the clinical development of Parabilis’ lead program, FOG-001, in colorectal cancer.

A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and ...

AdventHealth claims top spot; Cleveland Clinic elevated to Masters Category joining Mayo Clinic and Intermountain Healthcare.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third quarter ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third quarter 2024 investor letter.

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...